OTC Pharmaceuticals in Switzerland
MarketLine, March 2012, Pages: 36
Introduction
OTC Pharmaceuticals in Switzerland industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Switzerland otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
-The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.
-The Swiss OTC pharmaceuticals market generated total revenues of $1.3 billion in 2010, representing a compound annual growth rate (CAGR) of 1.8% for the period spanning 2006-2010.
-Cough and cold preparations sales proved the most lucrative for the Swiss OTC pharmaceuticals market in 2010, generating total revenues of $322.4 million, equivalent to 24.5% of the market's overall value.
-The performance of the market is forecast to decelerate, with an anticipated CAGR of 1.7% for the five-year period 2010-2015, which is expected to lead the market to a value of $1.4 billion by the end of 2015.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Switzerland
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Switzerland
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Switzerland otc pharmaceuticals market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the Switzerland economy
Key Questions Answered
What was the size of the Switzerland otc pharmaceuticals market by value in 2010?
What will be the size of the Switzerland otc pharmaceuticals market in 2015?
What factors are affecting the strength of competition in the Switzerland otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Switzerland's otc pharmaceuticals market?
TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 6
Market definition 6
Market analysis 6
MARKET DATA 7
Market value 7
MARKET SEGMENTATION 8
Category segmentation 8
Geography segmentation 10
Market share 11
Market distribution 12
MARKET OUTLOOK 13
Market value forecast 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
LEADING COMPANIES 20
Johnson & Johnson 20
Novartis AG 24
Bayer AG 27
MACROECONOMIC INDICATORS 31
Country Data 31
APPENDIX 33
Methodology 33
Industry associations 34
Related MarketLine research 34
LIST OF TABLES
Table 1: Switzerland OTC pharmaceuticals market value: $ million, 2006–10 7
Table 2: Switzerland OTC pharmaceuticals market category segmentation : % share, by value, 2006 - 2010 8
Table 3: Switzerland OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010 8
Table 4: Switzerland OTC pharmaceuticals market geography segmentation, by value, 2010 10
Table 5: Switzerland OTC pharmaceuticals market share: % share, by value, 2010 11
Table 6: Switzerland OTC pharmaceuticals market distribution: % share, by value, 2010 12
Table 7: Switzerland OTC pharmaceuticals market value forecast: $ million, 2010–15 13
Table 8: Johnson & Johnson: key facts 20
Table 9: Johnson & Johnson: key financials ($) 21
Table 10: Johnson & Johnson: key financial ratios 22
Table 11: Novartis AG: key facts 24
Table 12: Novartis AG: key financials ($) 25
Table 13: Novartis AG: key financial ratios 25
Table 14: Bayer AG: key facts 27
Table 15: Bayer AG: key financials ($) 28
Table 16: Bayer AG: key financials (€) 28
Table 17: Bayer AG: key financial ratios 29
Table 18: Switzerland size of population (million), 2006–10 31
Table 19: Switzerland gdp (constant 2000 prices, $ billion), 2006–10 31
Table 20: Switzerland gdp (current prices, $ billion), 2006–10 31
Table 21: Switzerland inflation, 2006–10 32
Table 22: Switzerland consumer price index (absolute), 2006–10 32
Table 23: Switzerland exchange rate, 2006–10 32
LIST OF FIGURES
Figure 1: Switzerland OTC pharmaceuticals market value: $ million, 2006–10 7
Figure 2: Switzerland OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010 9
Figure 3: Switzerland OTC pharmaceuticals market geography segmentation : % share, by value, 2010 10
Figure 4: Switzerland OTC pharmaceuticals market share: % share, by value, 2010 11
Figure 5: Switzerland OTC pharmaceuticals market distribution: % share, by value, 2010 12
Figure 6: Switzerland OTC pharmaceuticals market value forecast: $ million, 2010–15 13
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Switzerland, 2010 14
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Switzerland, 2010 15
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Switzerland, 2010 16
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Switzerland, 2010 17
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Switzerland, 2010 18
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Switzerland, 2010 19
Figure 13: Johnson & Johnson: revenues & profitability 22
Figure 14: Johnson & Johnson: assets & liabilities 23
Figure 15: Novartis AG: revenues & profitability 26
Figure 16: Novartis AG: assets & liabilities 26
Figure 17: Bayer AG: revenues & profitability 29
Figure 18: Bayer AG: assets & liabilities 30
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
